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Abstract
Green tea reportedly possesses many health beneficial effects as a beverage. Its usage has
even been elevated to therapeutic level for treatment of diseases, including cancer, after
increasing the catechin constituents in green tea extract or through purified catechins
compounds. However, the therapeutic effectiveness of green tea extract or catechin for-
mulae on different diseases is still questionable and inconsistent in reported studies. One
reason is the low and variable bioavailability of catechins or unknown constituents in
green tea extract. The plasma levels of total catechins are usually at submicromolar level
which is well below the effective dose in many in vitro studies. Besides their variable
chemical structures that cause heterogeneity of absorption, green tea catechins are subject
to extensive metabolism by phase II process and catabolism by colonic microbes that
result in complicated pharmacokinetics. It is essential to understand the factors affecting
the pharmacokinetics and metabolic profiles in plasma and tissues based on animal and
human studies before green tea catechins can be applied for therapeutic use.
Keywords: green tea extract, catechins, pharmacokinetics, bioavailability, absorption,
metabolism
1. Introduction
Tea is the most commonly consumed beverage in most populations across the world. Leaves of
the tea plant Camellia sinensis were processed by careful steaming and roasting to produce
green tea for drinks. The major biologically active constituent of green tea is polyphenols,
mainly catechins and their gallate derivatives: (+)-catechin (C), ()-epicatechin (EC), ()-
gallocatechin (GC), ()-epigallocatechin (EGC), ()-catechin-3-gallate (CG), ()-epicatechin-3-gal-
late (ECG), gallocatechin-3-gallate (GCG) and ()-epigallocatechin-3-gallate (EGCG) (Figure 1).
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Minor constituents include caffeine, theobromine, and theophylline. Among green tea catechins,
EGCG is the most abundant and biologically active based on animal and human studies [1, 2].
The biological activity is attributed to its structure moiety and hydroxyl groups [3].
Health benefits are evident for green tea catechins including anticancer [4] and antimicrobial
activities [5]. Cancer prevention has been found in the colon, duodenum, esophagus, stomach,
large intestine, liver, lung, mammary glands, and skin [6, 7]. There were in vitro anticancer
effects on adult T-cell leukemia (ATL) caused by a latent infection of human retrovirus HTLV-1
[8]. Drinking green tea could reduce HTLV-1 provirus load in asymptomatic HTLV-1 carriers
[9]. Although the underlying mechanisms for cancer-prevention is not well understood, their
antioxidation, free radical scavenger activities [10], and NF-κB inhibitory effect [11] have been
attributed as the major factors.
Although biological and intervention studies have indicated various beneficial effects, results
of clinical studies are not conclusive [12, 13]. Inconsistent findings may be attributed to
variations of methodologies and study conditions such as differences in infusion techniques,
consumption behavior, production methods, compositions of green tea constituents, and
absorption profiles, among different study cohorts. Pharmacokinetics of green tea catechins
have been studied using defined green tea catechin extract (GTE), Polyphenon E, and EGCG
with variable doses of administration [14, 15]. Oral bioavailability of tea catechins in human
plasma was found having 5 to 50 times lower than the level needed to exert biological activities
in in vitro systems [16, 17]. Other studies showed very high free EGCG peak plasma concen-
trations, 300, 1970, and 2020 ng/mL, after ingestion of 3, 5, or 7 capsules of Sunphenon DCF-1
(containing 225, 375, and 525 mg EGCG), which is a green tea extract obtained by a defined
protocol [18, 19]. Dosage affects the bioavailability of catechins. Many studies showed large
Figure 1. Structures of catechins.
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variations of bioavailability of catechins which is related to their beneficial effects. Understand-
ing the pharmacokinetics of catechins is important.
2. Pharmacokinetics of catechins
It is essential to know the effective concentrations and forms of catechins present in plasma
and tissues after ingestion. Pharmacokinetics is a study of the absorption, distribution, metab-
olism, elimination, and bioavailability of catechins following administration. In brief, after oral
administration of green tea or extract, catechins are absorbed from the small intestine and
remaining excess catechins pass to the colon. In the small intestine, catechins are conjugated
with glucuronic acid, sulfate or by O-methylation. Some catechins with secreted bile in an
enterohepatic recirculation process pass into the colon and are degraded into different flavo-
noid rings by resident microorganisms. The catabolized phenolic acids can be reabsorbed into
the circulation and excreted into urine. Catechins, their conjugated metabolites, and a large
amount of catabolized small phenolic acids can be distributed to various organs and tissues,
absorbed by tissue cells, further metabolized, and perform various biological actions (Figure 2).
Figure 2. Schematic diagram showing the absorption, distribution, metabolism, elimination of catechins in the body.
Thick and fill arrows indicate the flow of large amount of colon metabolites. Thin and hollow arrows depict low amount
of present catechins flowing in the body.
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3. Absorption
3.1. Conditions affecting absorption
Unlike other flavonoids, catechins exist as aglycone form. Their absorption is not influenced by
glucosidase digestion in the small intestine [20]. They can be absorbed directly across the
intestinal surface. The absorption depends on the physicochemical properties such as molecu-
lar size, steric configuration, solubility, hydrophilicity, pKa, and the presence of galloylated
derivatives [21]. The presence of food matrix and drugs in the intestinal cavity also influences
the absorption.
The oral bioavailability or catechins absorption is usually relatively low [22, 23]. The plasma
concentration is usually 5–50 times less than the effective biological active concentrations in
many in vitro studies [23]. In one study, green tea extract tablets containing 16.7 mg of EC,
44.9 mg of EGC, 11.1 mg of ECG, and 42.9 mg of EGCG were given to eight human subjects.
Their mean maximum plasma levels (Cmax) were 34.7, 60.6, 20.9, and 42.8 ng/mL, respectively
[24]. The absorption process of catechins and their metabolites may involve efflux transporters,
like multidrug resistance-associated protein 2 (MRP2), in the small intestine resulting in low
bioavailability [25]. It has been reported that ungallated catechins were effluxed by MRPs
expressed in a Caco-2 monolayer cells model [26]. In human, a non-proportional surge of area
under curve (AUC), Cmax, and total and free plasma level of EGCG appeared following
increase of oral dosage of a green tea extract (GTE) preparation, Polyphenon E, from 800 to
1200 mg [27]. It was possible that the efflux mechanism was saturated at higher dose causing
surge of catechins absorption at high dose.
P-glycoprotein (P-gp) is a transporter or efflux transporter for many molecules including
catechins [28, 29]. EGCG can interact with P-gp and affect the absorption of other drugs. On
the contrary, co-administration of some drugs can affect the absorption of green tea catechins
[30]. Polymorphisms of P-gp in human and in vitro studies were associated with variations of
Cmax and AUC of catechins after ingestion of green tea extract [31]. Competitive catechin-
drug interaction of transporters also reduced plasma concentration of β-blocker nadolol medi-
ated by organic anion-transporter OATP1A2 [32]. Oral catechins absorption can also be
affected by food intake. The average maximum free EGCG and EGC plasma concentrations in
human, following administration of the GTE Polyphenon E, increased 3.5-fold from the fasting
condition. While the total plasma levels of free and conjugated epigallocatechin (EGC) were
not affected, the plasma level of total epicatechins was lowered [33]. In addition, the bioavail-
ability of EGCG taken in capsule form was 2.7 and 3.5 times higher from fasting condition than
when taken with light breakfast or strawberry sorbet [34].
EGCG is stable in acidic condition as in the stomach but unstable in higher pH in the intestine.
After passing through the stomach, the EGCG present in the gastric juice is neutralized by
bicarbonate ions secreted by the pancreas in the duodenum where EGCG is degraded rapidly
[29, 33]. Only about 1% EGCG can be measured in the small intestines after 1-h incubation [35].
Although the acidic condition in a strawberry sorbet or fruit juice could protect EGCG, the
subsequently bicarbonate neutralization still leads to EGCG degradation. In addition, food can
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delay gastric emptying rate. The delay would subsequently reduce the Cmax (824.2  75.1 ng/
mL for EGCG without food; 231.8  134.3 ng/mL and 218.0  160.0 ng/mL with breakfast and
strawberry sorbet) due to prolonging the time to Cmax (Tmax) (60  34.6 min for EGCG
without food; 120  34.6 and 120  34.6 min with breakfast and strawberry sorbet).
3.2. Absorption in the presence of food
On the other hand, lower bioavailability is not due to the elimination difference in the presence
of food because the half-life of elimination was not significantly different between empty
stomach and with food [36]. Moreover, food components could irreversibly and reversibly
interact with catechins to affect their absorption in the proximal region of small intestine [37].
It also increased the viscosity of digestive fluid to reduce the dissolution of catechins [38], and
induced bile acid secretion to promote elimination of the absorbed catechins. These are factors
causing low oral and variable bioavailability of catechins. Despite catechins being stable in the
stomach, the oligomer form of catechins, proanthocyanidins, are hydrolyzed to monomer or
dimer in the acidic condition [39]. However, an in vivo study has not shown hydrolyzed
product present in the gastric juice [36].
Milk has been reported to reduce catechin absorption [11] due to interaction with protein
molecules [40]. Alcohol increased the solubility of catechins but did not increase plasma levels
of catechins [41]. Co-administration of butter with tea, on the other hand, could decrease the
Cmax of EGCG, EGC, EC, GCG, GC, and ECG by more than 40%. It also prolonged the mean
residence times (MRT) of free EGCG, EGC, EC, GC and ECG by more than 40%. However, the
levels of total (free and conjugated) catechins were not affected. Butter could modify catechins
metabolism by increasing the conjugation in the intestine possibly through increasing the
expression of UGT1A1 [42, 43]. Both forms of catechins excreted into feces increased from 124
to 232%. It suggests biliary secretion of EGCG, EGC, EC, GCG, and GC increased in response
to lipid absorption. Similarly, obese SD rats with hyperlipidemia also increased fecal excretion
of catechins from 0.52–1.3 to 1.2–3.4% when compared to normal rats. Lipids may alter the
metabolism and the relative proportions of the microflora in the colon [44] and, subsequently,
affect catechin catabolism. Since catechin catabolites have been attributed to many biological
activities [45], the consequence of suppressing catechins metabolism remains to be elucidated.
Furthermore, lipids can delay the gastric emptying causing Tmax increase [46]. Chocolate
supplement caused the Tmax delay from 1–2 to 3.2–3.8 h [47].
In contrast to a lipid meal, carbohydrate rich meals, could increase the oral bioavailability
(AUC) of flavanol by 140% [48]. The bioavailability of EGC and EGCG was significantly
enhanced when administered with mixture of GTE (50 mg), sucrose and ascorbic acid (3237.0
and 181.8 pmol*h/L respectively) comparing to green tea (1304.1 and 61.0 pmol*h/L plasma
respectively) in Sprague Dawley (SD) rats [49]. In addition, green tea mixed with vitamin C
and xylitol also improved flavanols absorption in human. The Cmax, Tmax, and AUC of
flavanols in plasma were 5980.58μg/mL, 2.14 h, and 18,915.56 h.μg/mL, respectively compar-
ing to the AUC of green tea control, 13,855.43 h.μg/mL. Sugar also delays gastric emptying,
that in turns delays the Tmax [50]. Ascorbic acid and sucrose can improve catechin absorption
through suppressing intestinal effluxing the absorbed catechins and stabilizing catechins in the
Pharmacokinetics and Disposition of Green Tea Catechins
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lumen. Consistently, there was 6–11 times increase in intestinal uptake of total catechins
comparing to green tea control following administered green tea with xylitol/citric acid and
xylitol/vitamin C [51].
Besides the effect of food and drug interaction, we found catechins absorption steric and
structural dependent [52]. In one study, we fed 550 mg/kg GTE to SD rats. After normalization
with the input oral doses, the relative AUC0-20 h of epi-isomers in the plasma was higher than
its enantiomers, with the level of EGC > GC, EC > C, and EGCG>GCG. Also, the plasma levels
of ungallated catechins (EGC, GC, and EC) were higher than gallated catechins (EGCG, GCG,
Figure 3. Diagrams showing the normalized relative AUC levels of total catechins (conjugated and free form) in ocular
fluid and tissues. (a) Relative AUC levels of different catechins in the plasma after normalization by the corresponding
input catechin dose in the GTE. Ungallate levels showed higher than gallate derivatives while epimers were higher than
non-epimers. (b) Relative AUC levels of catechins in vitreous and aqueous humor. Vitreous humor showed selective to
non-epimer but no selectivity on gallated and ungallated catechins. No particular trends of catechins selectivity appeared
in aqueous humor. (c) Relative AUC levels of catechins in retina, lens, cornea and choroids-sclera. Adapted from Chu et al.
[52].
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and ECG) (Figure 3). Catechins absorption should involve selective mechanisms and different
transporters. Moreover, when administrated with another GTE with higher proportion of
EGCG orally, the relative AUC of GC is higher than EC while other patterns of the AUC levels
remained the same [53]. It indicated that unknown interaction of absorptions between cate-
chins and EGCG promotes catechin absorption. In addition, although EGCG is dominantly
present in the GTE, its relative AUC level is very low, suggesting EGCG was not favorably
absorbed in the intestine (Figure 4).
4. Metabolism
4.1. Effects of conjugations
Catechins are mainly metabolized by phase 2 conjugation processes through methylation,
sulfation, and glucuronidation in the intestine and liver after oral administration. Glucuronidation
and sulfation mainly occur in the intestine, whereas glucuronidation, sulfation, and methylation
occur in the liver. Some conjugates are further methylated. Glucuronidation and sulfation can
increase the polarity of catechins to enhance solubility and facilitate their eliminations through
urine. EGCG, EGC and EC glucuronide and sulfate were commonly found in plasma [20, 27]. O-
methyl-EGC-O-glucuronides and O-methyl-EC-O-sulfates were found in human urine [54] and
Figure 4. Summary of factors influencing the bioavailability and absorption.
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methylated EGC conjugates were detected in human plasma after oral GTE administration [55],
but the metabolites were not found in plasma in the other study [56].
A large amount of catechins were further catabolized by microflora in the colon, reabsorbed
into plasma, and eliminated through urine. Major catechins catabolites were phenylvaleric
acid and phenylvalerolactones, such as 5-(30, 40, 50-trihydroxyphenyl)-γ-valerolactone (M4)
and 5-(30, 40-dihydroxyphenyl)-γ-valerolactone (M6) [57]. They can be further metabolized
and shortened to C6-C1 phenolic and aromatic acids, and then reabsorbed to enter the circula-
tion and excreted into urine. These small phenolic acids can be conjugated to valerolactone-
30-O-sulfate, pyrogallol-2-O-sulfate, Pyrogallol-2-O-glucuronide, and vanilloylglycine for excre-
tion in urine [58]. EGC and EC were metabolized into M4 andM6 and excreted likewise. EGCG
was metabolized to EGC and 5-(30,50-dihydroxyphenyl)-γ-valerolactone in the rat. The amount
of metabolites was about 6–39% of the ingested EGC and EC [59]. Elevated hippuric acid
(N-benzoylglycine) in excretion after green tea consumption by healthy volunteers comparing
to ileostomist also indicated extensive catabolism of catechins in the colon [60].
Owing to extensive metabolism, a wide variety of metabolites of catechins were found in
the plasma and urine after green tea consumption [61]. Ten metabolites, in the form of
O-methylated, sulfated, and glucuronide conjugates of EC and EGC, were identified in human
plasma, where only low levels, 55 and 25 nM, of intact EGCG and ECG were present. The
phase II catechin metabolites in urine were about 8% of the total catechin intake. Ileal fluid
from ileostomist fed with catechins contained about 33% parent compounds and 37% of 23
catechins conjugates, similar to healthy subjects [62]. About 70% of the ingested catechins that
were found as naïve catechins and conjugated metabolites, indicated that catechins were
mainly metabolized after glucuronidation, sulfation and methylation, and were effluxed back
into the lumen without extensive catabolism in the intestine. These compounds entered into
the colon and were subsequently hydrolyzed by resident microflora to remove the conjugated
moieties, releasing the aglycones and further catabolized into low molecular weight phenolic
acids by ring fission. Consequently, substantial amount of the gallated catechins (47% of input
dose) were detected in ileal fluid, and small amount of phenolic acids, pyrocatechol and
pyrogallol derived from the gallic acid moiety, were detected in human urine after green tea
consumption [63]. Other catabolites, 4-hydroxybenzoic acid, 5-(3,4,5-trihydroxyphenyl)-γ-
valeric acid, 3-(3-hydroxyphenyl)-3-hydroxypropionic acid, hippuric acid, 3-methoxy-4-
hydroxyphenylacetic acid, and 4-hydroxyphenylacetic acid, were also found in urine. These
phenolic acid catabolites account to about 40% of the intake, and would account for the major
biological activity of catechins instead of the low bioavailability of the parent compounds.
4.2. Microbial metabolism
The efficiency of microbial metabolism on catechins was well reported in a GTE study on cows
[64]. Different doses of GTE was applied intraruminally (10 and 50 mg/kg) and duodenally (10,
20 and 30 mg/kg BW) to dairy cows. No catechin could be found in the plasma for both doses
after intraruminal administration. However, plasma concentrations of EC, EGC, and EGCG
were increased on increasing dosage after intraduodenal administration. It demonstrated the
high metabolism efficiency of ruminal microorganisms under intraruminal administration.
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4.3. Effects of metabolism on pharmacokinetics
Catechins are suffered from extensive and different types of metabolisms. Also, some conju-
gates formation, like sulfates, are resistant to enzymatic hydrolysis during the sample prepa-
ration of chemical analysis [65]. These are reasons contributing to the large variation of
pharmacokinetics data in reported studies.
Catechins contain many epimers with different steric structures, the enantiomers are absorbed
and metabolized differently. For example, absorption of ()-C was lower than (+)-C [66]. A
study on metabolism of flavan-3-ols in human males ingested with equal quantities of ()-EC,
()-C, (+)-EC, and (+)-C reported different bioavailability. The plasma and urine showed
different levels of stereoisomers with ()-EC > (+)-EC > (+)-C > ()-C. Also, different levels of
non-methylated conjugations, and 30- and 400-O-methylation of epimers were found, indicating
stereoisomers can affect the metabolism of each other in the phase II metabolism [67]. Unlike
ungallated catechin, the conjugation of gallate derivatives, such as ECG and EGCG, were not
found in plasma and urine [68]. The galloyl moiety might inhibit phase II metabolism. In
another study, about 50% of ingested EGCG was found from ileal fluid in ileostomists indicat-
ing EGCG was hardly absorbed. Only 1% of phase II conjugate of EGCG was detected in ileal
fluid, showing excretion of EGCG directly from the enterocytes rather than being metabolized
in the liver and entering into the enterohepatic recirculation [69].
5. Distribution
Most distribution studies were conducted in rodents. In one study, green tea polyphenols (0.6%)
were given to rats for 8 days. Total (conjugated and free) EGC and EC levels were found in the
bladder, large intestine, kidney, lung, and esophagus at 2–3, 1–3, 1–2, 0.5–1, 0.5–0.7 micromole
levels, respectively. However, they were almost undetectable in spleen, liver, thyroid, and heart
[70]. The total EGCG levels in large intestine, esophagus, and bladder were 1.1, 0.61, and 0.44
micromoles while kidney, prostate, spleen, liver, and lung were undetected. In a 12-day study in
mice, Tmax of tea catechins in the lung and liver occurred on Day 4, but the level was decreased
from then on. Catechin concentrations in the lung were always higher than that in the liver [67].
In an EGCG study on rats at 500 mg/kg orally, the Cmax of EGCG in the small intestine mucosa,
colon mucosa, liver, plasma, and brain were 565, 69, 48, 12, and 0.5 μmol/L, respectively [68]. It
appears the level of distribution is related to the extent of catechins contact to the tissues.
Furthermore, we found that catechins can be distributed into various ocular tissues including
aqueous humor, vitreous humor, choroid-sclera, retina, lens, and cornea. After feeding 550mg/kg
GTE to SD rats, the Cmax of GC and ECG can reach to more than 10 and 1 μmol/kg, respec-
tively, in the choroid-sclera and retina and 1 μmol/kg in the lens [52] (Table 1). Levels of
catechins disposed in the ocular tissue could reach the effective dose. In our studies, green tea
extract can exert anti-oxidation, anti-inflammation and anti-apoptotic effects on the ocular
tissues especially for retina [52, 53, 69]. However, doubled the dose of EGCG in another GTE
resulted surge of EGCG deposing in the ocular tissues and caused the retina turning to
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pro-oxidative status and reducing the anti-apoptotic effect. Catechins disposition into ocular
compartments also exhibited steric selectivity. Vitreous humor was selective to non-epimer
catechins but without any structural preference to ungallated catechins as shown in the
plasma. Ocular tissues, on the contrary, did not show any specific disposition except GC was
dominated in retina, choroid-sclera, and the lens. Of note, it is our study on rat fetus. We also
found catechins can penetrate into various fetal tissues, including brain, eye, lung, heart, liver,
and kidney, following feeding to pregnant SD rat [71]. However, the Cmax levels of catechins
were below micromolar level. The effective biological activity on the fetus is still questionable.
Nevertheless, the Cmax of EGCG in the fetal eye could reach to 0.83 μM that may affect the
ocular development in this critical stage.
We have found GTE, Theaphenon® E, containing 70% EGCG, exerted biological effects on
various ocular diseases models. High oral dose of GTE, 550 mg/kg, suppressed various inflam-
mation responses in the iris and ciliary body, and aqueous humor following LPS-induced
ocular inflammation [69]. Our latest unpublished data also showed that it inhibited retina
inflammation through reduction of microglial cells and suppression of astroglial reactions. In
another sodium iodate-induced retina degeneration model, oral administration of 550 mg/kg
Theaphenon® E or catechins mixtures containing 438 mg/kg EGCG could protect retina from
disruptive folding caused by sodium iodate [72]. Such effects were possibly exerted through
their anti-oxidative effects as demonstrated by the reduction of 8-iso-PGF2α, superoxide
dismutase, and glutathione peroxidase levels in the retina. The anti-oxidative properties also
contributed to cataract inhibition, through cataracto-static ability as convincingly revealed by
Thiagarajan et al. [73]. The antioxidation protection was also supported by our previous study
[53]. Theaphenon® E increased the GSH/GSSG ratio and reduced 8-iso-PGF2α level in the lens,
although the catechins levels inside the lens was relative low comparing to other ocular tissues.
GC EGC C EC EGCG GCG ECG
Cmax (nM)
Plasma 91.5  57.4 754.9  235.8 139.0  57.0 1258.4  294.0* 310.4  59.9 50.8  10.4 159.1  33.9
Aqueous humor – 602.9  116.7* 127.4  62.8 138.9  58.5 13.2  5.1 33.5  20.4 47.8  8.1
Vitreous humor 110.6  22.1* 15.9  7.0 96.5  23.3* 20.5  10.6 15.4  2.7 20.9  9.9 14.0  5.1
Cmax (pmol/g)
Choroid-sclera 11461.8  5168.7* 1506.3  941.1 477.6 346.9 283.5  66.5 184.4  39.0 220.5  69.7 10.7  4.3
Retina 22729.4  4229.4* 8020.8  1658.49* 492.7 235.2 608.0  112.0 259.1  67.2 3.2  1.9 –
Lens 1558.1  318.4* 1172.3  207.8* 300.0 151.5 72.3  19.1 149.1  26.5 18.0  6.6 90.3  45.8
Cornea – 359.4  66.8* 58.5  15.4 30.6  5.7 25.2  15.5 10.7  3.9 91.1  18.7
Adapted from Chu et.al. [52].
* Indicates that the catechin(s) has significant higher (p < 0.05, n = 6) level of the parameter in the corresponding biological fluid or
tissue than the others as analyzed by compared by nonparametric Kruskal-Wallis H method.
Table 1. Maximum concentration of catechins in plasma, humors, eye tissues after a single dose of 550 mg/kg of
Sunphenon DCF-1 green tea extract administrated orally to rats.
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In a human study, green tea and black tea were given to patients 5 days prior to undergoing
prostatectomy surgery. Four main catechins were found in the prostate tissue ranging from 21 to
107 pmol/g [74]. Similar amount of EGCG and 400-O-methyl EGCG were found in the prostate
tissue in a following study [75]. Since only trace amounts of 400-O-methyl EGCG were present in
human plasma after green tea consumption, it suggested that catechol O-methyltransferase was
present in prostate to methylate EGCG [76].
6. Elimination
Catechins are mainly cleared through urinary and biliary excretion. Non-galloylated catechins
are mainly excreted in urine in the form of parent and conjugated compounds. Galloylate
catechins are mainly excreted through biliary excretion to the colon. In one study, minor epi- or
gallocatechin-O-sulfates were detected in urine, while aglycones, ECG and EGCG, were absent
after green tea consumption [68]. No conjugates of ECG and EGCG were detected in urine
suggesting the gallate derivatives did not undergo phase II metabolism. The flavan-3-ol metab-
olites excreted were equivalent to 8.1% of ingested green tea flavan-3-ols [68]. Other studies
found catechin metabolites accounted for 28.5% of intake, whereas gallocatechin metabolites
accounted for 11.4% of the ingested ()-epigallocatechin and (+)-gallocatechin [77]. EGCG can-
not be detected in urine showing its elimination is not renal. On the other hand, EGCG may be
degalloylated to other catechins in the liver after absorption through small intestine, subse-
quently metabolized and eliminated into urine resulting EGCG absent in there. However, EGCG
and its metabolites could not be found in ileostomists urine suggested EGCGwas not eliminated
through the internal degalloylation process [78] because EGCG could be absorbed through colon
and eliminated directly into urine. In addition, the half-lives of non-gallated catechins, EGC and
EC, were shorter than gallated catechins, EGCG and ECg [31]. It may be because the more
hydrophobic gallated catechins bind stronger to serum proteins and exist in non-conjugated free
form that is not favorable for renal excretion [79, 80]. On the other hand, oral administration of
catechins in rats found relative amounts of EC, EGCG, and ECG, respectively, at 4.72, 0.17, and
0.25% in urine and 11.0, 7.89, and 5.80% in feces [81]. In an isotope tracing study in rats, about
77% of the total radioactivity was present in bile but only 2.0% in the urine after intravenous
administration of [4-3H]-EGCG [82]. These evidences suggested that the galloyl catechin are
excreted through the bile and eliminated through the feces.
In our study on GTE, Sunphenon, the elimination rates of catechins in retina and choroid-
sclera were in general higher than the humors and plasma. The elimination rate was from
0.19 h1 for GC to 2.4 h1 in the retina, while the rate was from 0.04 for EGC to 0.24 for ECG in
vitreous humor in SD rats [52]. However, when the dose of EGCG was doubled in another
GTE, Theaphenon® E, we found the elimination rates of all catechins in the ocular tissues,
particularly the retina, lower than the plasma [53] (Table 2). It appeared that some active
elimination or metabolic mechanisms in ocular tissues facilitated the elimination. The elimina-
tion mechanism actively removed the catechins in the ocular tissues, but the mechanism was
suppressed by the increased EGCG concentration. On the other hand, in our rat fetus study,
Pharmacokinetics and Disposition of Green Tea Catechins
http://dx.doi.org/10.5772/intechopen.74190
27
the elimination rates of catechins in the maternal plasma, in general, were faster than the fetal
tissues. The elimination rate of GC and EC were 0.26 and 0.3 h1 for maternal plasma, whereas
0.08 and 0.1 h1 for fetal kidney [71].
7. Conclusions
Many pharmacokinetics studies of green tea catechins were conducted on rodents and less
studies in rabbits, dogs, or human. Most of them are oral administration studies. Although the
plasma levels of total catechins are at submicromolar level, which is below the effective dose in
many in vitro studies, tissue dispositions could be much higher. Ungallated catechins are
mainly metabolized by phase II process in the small intestine and liver to form glucuronide/
sulfate conjugates in the plasma and urine while gallated catechins mostly remain intact in the
plasma and are excreted through bile and metabolized by microflora in the colon. High levels
of small metabolized phenolic acids can be reabsorbed into blood stream that may contribute
to the in vivo biological effects.
GC EGC C EC EGCG GCG ECG
λz (h1)
(a)
Plasma 0.107  0.010 0.213  0.015 0.104  0.038 0.371  0.000* 0.236  0.007 0.171  0.013 0.211  0.010
Aqueous humor – 0.045  0.001 0.209  0.012 0.093  0.062 0.304  0.012* 0.111  0.033 0.124  0.043
Vitreous humor 0.166  0.010 0.041  0.001 0.106  0.030 0.067  0.004 0.058  0.012 0.042  0.006 0.224  0.035*
Choroid-sclera 0.057  0.001 0.461  0.015 0.220  0.014 0.488  0.007 0.267  0.019 0.929  0.049* –
Retina 0.188  0.045 0.203  0.050 0.245  0.010 2.432  0.154* 0.413  0.040 – –
Lens 0.302  0.049* 0.084  0.020 0.234  0.032 0.049  0.004 0.269  0.011 3.16  0.13 –
Cornea – 0.170  0.031 0.116  0.007 0.043  0.012 0.125  0.001 0.372  0.006 0.477  0.021*
(b)
Plasma 0.27  0.03 0.39  0.04 0.37  0.08 0.40  0.05 0.23  0.02 1.25  0.38 0.21  0.04
Aqueous humor 0.11  0.02 0.24  0.02 0.13  0.03 0.21  0.04 0.09  0.02 – 0.13  0.12
Vitreous humor 0.02  0.01* 0.11  0.09 0.11  0.06 0.10  0.03 0.08  0.02 – –
Choroid-sclera – 0.25  0.09 0.22  0.09 0.37  0.06 0.08  0.04* – 0.15  0.07
Retina – 0.04  0.03 0.04  0.01 0.06  0.02 0.04  0.02 – 0.09  0.03
Lens – – – – 0.13  0.06 – –
Cornea – – 0.22  0.10 0.22  0.10 0.09  0.02* – 0.10  0.09
Adapted from (a) Chu et al. [52] and (b) Chu et al. [53].
* Indicates that the catechin(s) has significant higher (p < 0.05, n = 6) level of the parameter in the corresponding biological fluid or
tissue than the others as analyzed by compared by nonparametric Kruskal-Wallis H method.
Table 2. Elimination of catechins in plasma, humors, eye tissues after a single dose of 550 mg/kg of (a) Sunphenon DCF-1
green tea extract, and (b) Theaphenon® E administrated orally to rats.
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Catechins can be widely distributed into various tissues including lung, eye, brain, gastroin-
testinal tract, kidney, bladder, and even passing through the placenta to the fetal organs. The
disposition can be stereo-specific, and affected by food, drug, and catechins themselves indi-
cating the absorption and distribution may involve some sort of transporters mechanisms.
Before applying green tea catechins for therapeutic purpose, it is essential to understand their
pharmacokinetics behavior and metabolites profiles not only in the plasma but also in various
tissues in animals and in humans.
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